Valvular heart disease (VHD) is a major contributor to loss of physical function, quality of life
and longevity. The epidemiology of VHD varies substantially around the world, with a …

Valvular heart disease is a rapidly growing cause of global cardiovascular morbidity and
mortality with diverse and evolving geographic distribution. The prevalence of rheumatic …

The recommendations listed in this document are, whenever possible, evidence based. An
extensive review was conducted on literature published through March 1, 2020. Searches …

Aim This executive summary of the valvular heart disease guideline provides
recommendations for clinicians to diagnose and manage valvular heart disease as well as …

Valvular heart disease (VHD) is the next epidemic in the cardiovascular field, affecting
millions of people worldwide and having a major impact on health care systems. With aging …

Objective. Cardiovascular diseases (CVDs) are a main cause of deaths all over the world.
This research focuses on computer-aided analysis of phonocardiogram (PCG) signals …

Tricuspid regurgitation (TR) has long been a forgotten valve disease of benign reputation.
However, TR deserves higher attention and represents a growing public health crisis …

Despite numerous promising therapeutic targets, there are no proven medical treatments for
calcific aortic stenosis (AS). Multiple stakeholders need to come together and several …

Background For patients with asymptomatic, severe aortic stenosis (AS) and preserved left
ventricular ejection fraction, current guidelines recommend clinical surveillance every 6 to …

Aims With an ageing population, the presence of asymptomatic valvular heart disease
(VHD) in the community remains unknown. The aim of this study is to determine the …